Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Poulin-Costello

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|April 11, 2003
Intravenous immune globulin use in CanadaKim Hanna, Melanie Poulin-Costello, Mark Preston, et al.
Dermatology (Basel, Switzerland)|March 1, 2013
Incomplete data in randomized dermatology trials: consequences and statistical methodologyMichael A McIsaac, Richard J Cook, Melanie Poulin-Costello
Canadian Respiratory Journal|December 22, 2004
Symptom resolution in patients with Mycoplasma pneumoniae pneumoniaThomas J Marrie, Michael Beecroft, Zeljka Herman-Gnjidic, et al.
Applied Health Economics and Health Policy|August 11, 2012
Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical settingRonald Vender, Charles Lynde, Vincent Ho, et al.
Respiratory Medicine|January 28, 2005
Etiology of community-acquired pneumonia treated in an ambulatory settingThomas J Marrie, Melanie Poulin-Costello, Michael D Beecroft, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian populationRonald Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2015
Predictors of Topical Use in Psoriasis Patients in the REFINE StudyMelinda J Gooderham, Melanie Poulin-Costello, Jennifer Shelton, et al.
Journal of Cutaneous Medicine and Surgery|November 15, 2012
Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practiceRon Vender, Charles Lynde, Martin Gilbert, et al.
Targeted Oncology|April 30, 2013
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancerMelanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, et al.
Annals of the Rheumatic Diseases|August 28, 2013
The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritisJanet E Pope, Boulos Haraoui, J Carter Thorne, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|April 11, 2003
Intravenous immune globulin use in CanadaKim Hanna, Melanie Poulin-Costello, Mark Preston, et al.
Dermatology (Basel, Switzerland)|March 1, 2013
Incomplete data in randomized dermatology trials: consequences and statistical methodologyMichael A McIsaac, Richard J Cook, Melanie Poulin-Costello
Canadian Respiratory Journal|December 22, 2004
Symptom resolution in patients with Mycoplasma pneumoniae pneumoniaThomas J Marrie, Michael Beecroft, Zeljka Herman-Gnjidic, et al.
Applied Health Economics and Health Policy|August 11, 2012
Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical settingRonald Vender, Charles Lynde, Vincent Ho, et al.
Respiratory Medicine|January 28, 2005
Etiology of community-acquired pneumonia treated in an ambulatory settingThomas J Marrie, Melanie Poulin-Costello, Michael D Beecroft, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian populationRonald Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2015
Predictors of Topical Use in Psoriasis Patients in the REFINE StudyMelinda J Gooderham, Melanie Poulin-Costello, Jennifer Shelton, et al.
Journal of Cutaneous Medicine and Surgery|November 15, 2012
Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practiceRon Vender, Charles Lynde, Martin Gilbert, et al.
Targeted Oncology|April 30, 2013
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancerMelanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, et al.
Annals of the Rheumatic Diseases|August 28, 2013
The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritisJanet E Pope, Boulos Haraoui, J Carter Thorne, et al.
Pageof 3